Orphan Drug Designation in Soft Tissue Sarcomas Expands Company’s Potential to Address Cancers with High Unmet Medical Need CHICAGO and FORT WORTH, Texas, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Actuate ...
Fort Worth, Texas, clinical-stage biopharmaceutical company Actuate said elraglusib has shown a favorable safety profile and antitumor activity across several solid tumors, including melanoma, Ewing ...
Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers, including ...
I'm sure the discussion is going to be fascinating. I'm told that, Kevin, this is -- this maybe the first time ever at an investor conference, a Chief Technology Officer of the world's, I think still ...
Glorious has finally released the GMMK 3, and it goes far beyond being just another mechanical keyboard. It wants to be the last keyboard you ever buy.